LONG COVID19
Clinical trials for LONG COVID19 explained in plain language.
Never miss a new study
Get alerted when new LONG COVID19 trials appear
Sign up with your email to follow new studies for LONG COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can antivirals beat long COVID? major trial tests new hope
Disease control CompletedThis study tested whether antiviral drugs and other treatments can help people with Long COVID by targeting lingering virus or immune system problems. Nearly 1,000 adults with a history of COVID-19 took part in this flexible, multi-center trial. The goal was to see if these treat…
Matched conditions: LONG COVID19
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New study tackles long COVID's dizziness and heart woes
Symptom relief CompletedThis study tested different treatments for people with Long COVID who have problems with their autonomic nervous system, such as POTS (a condition causing dizziness and rapid heartbeat). The trial included 381 adults and compared non-drug approaches with medications to see which …
Matched conditions: LONG COVID19
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Symptom relief
Last updated Jun 16, 2026 23:04 UTC
-
New rehab program shows promise for long COVID sufferers
Symptom relief CompletedThis study tested a 6-week outpatient rehab program for 125 adults with Long COVID. The program included breathing exercises, strength training, and cognitive therapy to help with symptoms like fatigue, brain fog, and shortness of breath. The goal was to see if this program could…
Matched conditions: LONG COVID19
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 12, 2026 12:07 UTC
-
Can we fix long COVID fatigue? major trial tests exercise-boosting treatments
Symptom relief CompletedThis study tested different treatments to help people with Long COVID who struggle with exercise and feel very tired after activity. 660 adults took part across multiple medical centers. The goal was to find ways to improve daily activity and quality of life.
Matched conditions: LONG COVID19
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 12, 2026 12:06 UTC
-
Long-COVID sufferers find relief through Self-Management program
Symptom relief CompletedThis pilot study tested a program called 'Tomando control de su salud' (Taking Control of Your Health) in 47 adults with Long-COVID and other chronic conditions in Puerto Rico. The program taught self-management skills to improve quality of life, fatigue, and anxiety. Researchers…
Matched conditions: LONG COVID19
Phase: NA • Sponsor: University of Puerto Rico • Aim: Symptom relief
Last updated Jun 11, 2026 11:57 UTC
-
Diet and fasting show promise for long COVID relief
Symptom relief CompletedThis study looked at whether a no-added sugar diet, eating only during a set daily window, and doing one or two full-day water fasts each week could ease Long COVID symptoms. 77 adults with at least five Long COVID symptoms took part. The goal was to see if these diet changes cou…
Matched conditions: LONG COVID19
Phase: NA • Sponsor: Pacific Northwest University of Health Sciences • Aim: Symptom relief
Last updated Jun 10, 2026 13:27 UTC
-
New study aims to ease exercise struggles for long COVID sufferers
Symptom relief CompletedThis study tested different methods to help people with Long COVID who have trouble exercising or feel very tired after activity. About 300 adults who developed these symptoms after a COVID-19 infection took part. Researchers compared approaches like structured pacing to see if t…
Matched conditions: LONG COVID19
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 08, 2026 13:03 UTC
-
Can a heart drug ease long COVID's dizzying effects?
Symptom relief CompletedThis study tested whether ivabradine, a heart medication, can reduce symptoms like dizziness and rapid heart rate in people with long COVID. 181 participants received either ivabradine or a placebo. The goal was to see if the drug improves daily activities and symptom severity.
Matched conditions: LONG COVID19
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Symptom relief
Last updated May 26, 2026 12:11 UTC